McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.

Revenue
+7.57%
EPS
+17.0%
Free cash flow
+32.5%
Total debt
+7.08%

Quarter to September 2026, against a year earlier

1,068.22 3.78 −0.35%
Market cap
$125.0B
P/E
27.5×
Fwd P/E
25.4×
Dividend yield
0.32%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100

McKesson Corporation 10-Q filed Nov 4, 2026

Fiscal Q2 2027 · Period ended Sep 30, 2026 · Filed · accepted 5:30 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Nov 6, 2025: 35 added · 34 removed · 59 modified; 13 with only figures updated; 13 moved without change